Oral versus rectal diclofenac in the control of uterine cramping pain following vaginal delivery: A randomized study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202507562515638

Enrollment

142

Registered

2025-07-25

Start date

2023-06-26

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

oral diclofenac sodium

rectal diclofenac

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All women who had spontaneous vaginal delivery in the labour room of FMC Keffi and are ready to give informed consent.

Exclusion criteria

Exclusion criteria: • Women with chronic history of pain • Women who sustained cervical, vaginal laceration or developed postpartum haemorrhage. • Women who had epidural analgesia in labour. • Women who have contraindication to diclofenac use such as women with peptic ulcer disease, asthmatic patients.

Design outcomes

Primary

Measure	Time frame
Rectal diclofenac sodium was more effective in relieving uterine cramping pain postpartum	—

Secondary

Measure	Time frame
1. Parturients have a better satisfaction for rectal diclofenac sodium than oral diclofenac sodium. 2. There were less side effect with rectal diclofenac sodium than oral diclofenac sodium.	—

Countries

Nigeria

Contacts

Public ContactAdeola Afolabi

Supervisor

drafolabiaf@gmail.com+2348033734508

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026